Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2022
23 minute read | July.27.2022
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
Search Results
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022
April.26.2022
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2022
22 minute read | February.16.2022
A Conversation on the Future of Longevity, Cell Regeneration and Senescence
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2021
23 minute read | October.19.2021
VC Investment Surges in European Life Science
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021
14 minute read | July.21.2021
A Conversation on Spinouts – Unlocking Market Value and Creating Business Opportunities
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2021
22 minute read | April.20.2021
Record-breaking Markets and a Candid Conversation on University Spinouts
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q1 2021
18 minute read | February.01.2021
We review full-year 2020 data in depth to identify and summarize the key trends that shaped venture investment across the sector.
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q3 2020
9 minute read | October.22.2020
Venture Surges and the Rise of SPACs
In this edition, the traditional update on broader venture market financing data is included.
In this edition, the traditional update on broader venture market financing data is included.
Insight
California Legislature Passes AB 979 Requiring Public Companies to Add Directors From Underrepresented Communities
September.01.2020
On August 31, 2020, the California State Assembly Banking and Finance Committee voted to give final legislative approval to Assembly Bill 979 (AB ...
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q2 2020
10 minute read | August.10.2020
Companies & Investors Navigate the Pandemic Era
In this new series, we explore trends in venture investing across the life sciences sector.
In this new series, we explore trends in venture investing across the life sciences sector.
Insight
COVID‐19 Investment Scams Become Focal Point of Securities Regulators
by Albert Vanderlaan and Gregg Griner
June.16.2020
The Massachusetts Securities Division (the Division) warns that the average investor is overwhelmed by the COVID-19 pandemic.
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q1 2020
12 minute read | May.11.2020
The Market Meets COVID-19
In this new series, we explore trends in venture investing across the life sciences sector.
In this new series, we explore trends in venture investing across the life sciences sector.